Follow the Covalon Technologies Ltd. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares trade on CA CA, under the oversight of SEDI. Market capitalisation: €61m. The latest transaction was disclosed on 12 June 2026 (56 - Grant of rights). Among the most active insiders: Miller, Murray. The full history is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,403 of 28,093 companies
51.4
score / 100
Value
41
Quality
61
FCF yld2.3%
Earn yld3.3%
EV/EBITDA23.6x
ROE5.5%
Gross mgn53%
Net mgn6.3%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Covalon Technologies Ltd. is a company focused on the development of medical technologies and healthcare products. It specializes in innovative solutions to enhance clinical outcomes and the quality of care.